State of health and care: The NHS Long Term Plan after COVID-19

State of Health reportState of health and care: The NHS Long Term Plan after COVID-19

A new report from IPPR shows the extent to which the coronavirus pandemic has disrupted progress on the NHS Long Term Plan. The report looks at cancer, mental illness, cardiovascular disease and multiple long term conditions, but the findings are equally relevant to MSK services.

The report argues that COVID-19 should not become an excuse for low ambition, and that world-class healthcare must remain the overall goal. To achieve this, the report recommends a package of six ambitious changes designed to do three things:

  • Ensure the pandemic does not cause lasting damage to healthcare services for future generations.


Read more of this article

Workforce planning chart for MSK

The launch of NHS England’s Best MSK Health programme gives the population’s musculoskeletal health in England a focus and priority like never before, and much needed in the wake of the COVID-19 pandemic. 

NHS England waiting times data shows people with serious MSK conditions needing diagnosis and treatment by rheumatology and elective care services are waiting much longer. The same is true for community MSK services and treatment. At the other end of the spectrum, for people who previously had no long-term conditions, the lockdown effect on mental well-being, exercise and weight-gain are significant obstacles to their musculoskeletal health now and into the future.…

Read more of this article

Key MSK COVID-19 resources

ARMA continues to keep our COVID-19 resources page up to date. There have been some new resources added in recent weeks and others have become more relevant as the pressure on the NHS increases. Here are some of the key resources to be aware of:-

Urgent and Emergency Musculoskeletal Conditions Requiring Onward Referral

The guidance supports primary and community care practitioners in recognising serious pathology which requires emergency or urgent referral to secondary care in a patient who presents with new or worsening MSK symptoms.…

Read more of this article

CEO update: Looking forward together

by Sue Brown, CEO ARMA

Here we are back in lockdown, with the NHS under even more pressure and MSK services severely impacted. COVID-19 response is still dominating the work of ARMA, although we are also progressing plans for other work in 2021. There are some different issues for MSK this time around, and vaccination currently dominates our work. When some people with MSK conditions are vaccinated, the timings of MSK treatment may need to be considered.

I am delighted that ARMA can host a document setting out the principles for these timing decisions.…

Read more of this article

Inclusion Health: applying All Our Health

Public Health England
Guidance

Inclusion Health: applying All Our Health

Published 11 January 2021

Published by Public Health England, this guide is part of ‘All Our Health’, a resource that helps health and care professionals prevent ill health and promote wellbeing as part of their everyday practice. The information below will help front-line health and care staff use their trusted relationships with individuals, families and communities to take action on inclusion health.

‘Inclusion health’ is a catch-all term used to describe people who are socially excluded, typically experience multiple overlapping risk factors for poor health (such as poverty, violence and complex trauma), experience stigma and discrimination, and are not consistently accounted for in electronic records (such as healthcare databases).…

Read more of this article

Royal College of GPs and EDS toolkit

by Ehlers-Danlos Support UK

We were very disappointed to be told just before Christmas that the Royal College of GPs (RCGP) wanted to withdraw the Ehlers-Danlos syndromes (EDS) toolkit for GPs. The College planned to remove the toolkit from the RCGP website at the end of January. The RCGP cited pressure on its limited resources as a result of the pandemic and contention around the toolkit from various sources as reasons for its decision. While we understood that the College wanted to prioritise use of its resources, the move would have been a huge backwards step for people with EDS and related conditions.…

Read more of this article

NHFD Annual Report

The challenge of the next decade: are hip fracture services ready?

The National hip Fracture Database (NHFD) has recently released its latest annual report focussing on the six NHFD key performance indicators used to monitor and drive up standards across the country. 2020 will no doubt prove to be one of the most challenging years in the history of the NHS. This report also presents the first data about the effect of COVID-19 on trauma units around the country and on outcome for patients with hip fracture who have COVID-19 when admitted to hospital or develop it after their operation.…

Read more of this article

COVID-19 vaccination and MSK

ARMA BSR BOA RAIRDA

Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians

(Version 12, 12 September 2022)

Amendment 12th September 2022: Document updated to include latest JCVI and NHSE guidance regarding autumn boosters using second generation bivalent COVID-19 vaccines and results of VROOM study (see section 23 and section 24 respectively)

Amendment 3rd April 2022: Document updated to include latest JCVI and NHSE guidance regarding spring 2022 boosters (see section 22)

Amendment 3rd December 2021: Document updated to include latest JCVI guidance regarding boosters for patients who were eligible for a third primary dose (see end of section 21)

Amendment 13 October 2021: Document updated to include revised BSR wording about third primary dose (section 20).

Read more of this article

Urgent and Emergency Musculoskeletal Conditions Requiring Onward Referral

Updated guidance was published in December to support primary and community care practitioners in recognising serious pathology which requires emergency or urgent referral to secondary care in people with new or worsening MSK symptoms. Serious pathology as a cause of MSK conditions is considered rare, but it needs to be managed either as an emergency or as urgent onward referral as directed by local pathways. Any part of the MSK system can be affected.

Emergency conditions are serious pathologies which must be dealt with on the day as an emergency.…

Read more of this article